Introduction
Cervical cancer is the third commonest cancer in women, and the seventh overall, with an estimated 530 000 new cases in 2008. More than 85% of the global burden occurs in developing countries, where it accounts for 13% of all female cancers. High-risk regions are Eastern and Western Africa (ASR greater then 30 per 100 000), Southern Africa (26.8 per 100 000), South-Central Asia (24.6 per 100 000), South America and Middle Africa (ASRs 23.9 and 23.0 per 100 000, respectively). Rates are lowest in Western Asia, Northern America and Australia/New Zealand (ASRs less than 6 per 100 00) [1] . The different incidence in different areas indicates the genetic factors and environmental factors play a role in the development of cervical cancer.
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Materials and methods

Selection criteria and search strategy
Identification of relevant studies was carried out through a search of Medline and EMbase up to May 2011 using the following terms without any restriction on language: 1)cervical$. ab, ti; 2) (carcino$ or cancer$ or neoplasm$ or tumour$ or tumor$). ab, ti; 3) adenocarcinoma$. ab, ti; 4) or/2-3; 5) 1 and 4; 6) (glutathione S-transferase or GST or GSTM or GSTM1). ab, ti; 7)5 and 6.
The literature search was performed up to December 2011. The inclusion criteria were as following: case-control studies that investigated the association between GSTM1 polymorphism and risk of cervical cancer; Studies presented original data and the number of null genotype of GSTM1 in cases and controls. For each study, the following information were excluded: name of the first author, publication year, ethnicity(county), number of cases and controls; number of null genotype for GSTM1 in cases and controls. Two authors independently assessed the articles for inclusion/exclusion, resolved disagreements, and reached consistency.
Statistical analysis
The association between GSTM1 polymorphism and cervical cancer was estimated by calculating pooled ORs and 95% CIs. The significant of the pooled OR was estimated by Z test (P<0.05 was considered statistically significant). The I 2based Q statistic test was performed to evaluate variations due to heterogeneity rather than chance. A random-effects or fixed effects methods [13, 14] model was used to calculate pooled effect estimates in the presence (P≦0.1) or absence (P>0.1) of heterogeneity. Begg's funnel plot, a scatter plot of effect against a measure of study size, was generated as a visual aid to detecting bias or systematic heterogeneity [15] . As asymmetric funnel plot indicated a relationship between effect and study size, which suggested the possibility of either publication bias or a systematic difference between smaller and larger studies (small study effects). Furthermore, publication bias was assessed by Egger's test [16] . Studies were categorized into subgroups based on ethnicity and smoking status. The data analysis was performed (STATA, version 10, StataCorp LP, College Station, TX).
Results
The literature search identified 132 potentially relevant studies. Of the 132 literatures, 104 literuatures were irrelevant, and 5 studies were excluded because of various reasons (2 study was conducted on overlapping population, and 3 studies did not include controls in analysis). Finally, 15 literatures met the inclusion criteria and were included. 15 case-control studies were included in the meta-analysis of GSTM1 genotypes (1 825 cases and 2 104 controls). For the meta-analysis of GSTM1, 2 studies on China, 4 studies on India, 3 studies on Japan, 2 studies on Korea, 2 studies on Italy, one study in America and Thailand. There were 994 cases of null genotype and 934 controls of null genotype, with adjusted OR as 1.14(0.95-1.32). Study characteristics included in the meta-analysis are presented in Table 1 , and P for heterogeneity was <0.05.
The forest plot of the meta-analysis of GSTM1 is shown in Figure 1 . Because of the heterogeneity among studies (P Q <0.001, I 2 =74.5%), a random-effects model was used. The overall result showed that the association between GSTM1 null genotype and risk for cervical cancer was statistically significant (OR=1.54, 95%CI=1.18-2.00). The adjusted pooled OR(95%CI) of GSTM1 null genotype for cervical cancer were 1.14(0.95-1.32). No significant increased risk of cancer was observed, and also great heterogeneity was found between studies.
Odds ratio (95% CI) Subgroup analysis was performed based on smoking and ethnicity (Figure 2 and 3 ). The result showed that smokers with null GSTM1 genotype had higher risk of cervical cancer (OR=1.56, 95%CI=1.01-2.41), while no significant increased risk was found in non-smokers. After stratification, the heterogeneity was significantly decreased (P=0.09 for non smokers and P=0.12 for smokers). For the ethnicity stratification, significant increased risk of null GSTM1 genotype was found in Chinese (OR=1.85, 95%CI=1.30-2.63) and Indian population (OR=2.07, 95%CI=1.49-2.88), but no increased risk in other population. However, no significant decreased risk was found in American population. Begg's funnel plot were generated to assess potential publication bias for GSTM1 (Figure 4 ), and the symmetry of the studies in the funnel plot showed no publication bias in this meta-analysis. The Egger's test showed no publication bias for GSTM1 (P value was 0.11). Moreover, the sensitivity analysis showed the robust of our meta-analysis after excluding an large sample size study [19] . 
Discussion
Previously, genetic factors are considered as important factors in the development of cervical cancer. Previously, many studies investigated the association between GSTM1 polymorphism and cervical cancer. However, the association between them is controversial. Some studies reported that the null genotypes are positively correlated, inversely correlated, or not correlated with with the risk for cervical cancer in different ethnic populations. These discrepancies could have been due to limited sample numbers and ethnic differences. Therefore, we conducted a meta-analysis of 15 published case-control studies to investigate the role of GSTM1 polymorphism in cervical cancer. The metaanalysis result showed that the association between GSTM1 null genotype and the risk for cervical cancer is statistically significant in smokers, and Chinese and Indian population but not in other populations.
Many studies have reported the effect of ethnic differences on genetic predisposition to human diseases. For example, the incidence of cervical cancer is high in southern Africa, and is almost five-folds higher than in the Northern America and Australia [1] . It showed there were differences in ethnicities or in environment. In addition, the data showed that the allele frequency of GSTM1 null genotype was higher in American and Japanese than in Chinese and India populations. In the present study, we found that the association between GSTM1 null genotype and the risk of cervical cancer was statistically significant in Chinese and Indian but not in other populations. The reasons of the variation in the effect of the genotype might be the different of lifestyle, nutrition, environmental factors, and genetic factors in different ethnicities.
The association between cervical cancer and cigarette smoking has been discussed since the late 1970s, and numerous studies represented by Winkelstein [28] and the IARC Multi-centre Cervical Cancer Study Group [29] have reported that the risk of developing cervical cancer was elevated two-to three-folds by smoking after adjusting for HPV infection status. Our study showed the cigarette could play an interaction role with null GSTM1 genotype, those smokers carrying the null genotype possessed increased susceptibility to cervical carcinogenesis.
There are some limitations to this meta-analysis. Firstly, the sample size reported in the literature is still relatively small and might not provide sufficient power to estimate the association between the null GSTM1 polymorphism and cervical cancer risk. Secondly, it is widely recognized that environmental risk factors, such as exposure to HPV infection, cervical lesion type and genital health are major contributors to cervical cancer development. Understanding the interaction between environmental exposure and null GSTM1 polymorphism is an important priority; however, the lack of available data precludes examination of geneenvironment interactions in this meta-analysis. Our sensitivity analysis showed that the combined ORs did not change after the exclusion of studies with large sample size, suggesting that our results are methodologically robust. Begg's test also showed no evidence of potential publication bias, indicating that the preferential publication of positive results does not occur.
In conclusion, this meta-analysis provide strong evidence that the GSTM1 null genotype is associated with the development of cervical cancer, and especially in Chinese and Indian population, and smokers showed a modification on the association between GSTM1 null genotype and cervical cancer. Well-designed and large sample studies should be performed to confirm this finding. Also, further studies investigating the effect of gene-environment interactions on cervical cancer risk are required.
